FM
HRTX icon

Forward Management’s Heron Therapeutics HRTX Stock Holding History

Forward Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-74,575
Closed -$848K – 282
2015
Q2 		$848K Buy
+74,575
New +$1.4M 0.05% 204
2014
Q4 		– Sell
-135,748
Closed -$1.42M – 405
2014
Q3 		$1.42M Buy
135,748
+64,827
+91% +$604K 0.09% 138
2014
Q2 		$822K Sell
70,921
-22,093
-24% -$264K 0.05% 171
2014
Q1 		$1.13M Buy
+93,014
New +$1.24M 0.06% 139

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Forward Management's HRTX Position: Q3 2015 in Review

Forward Management sold out of Heron Therapeutics (HRTX) in Q3 2015, closing a stake of 74,575 shares — an estimated $848K sold.

Forward Management first reported a position in HRTX in Q1 2014 and held it in 4 quarters. The position peaked at $1.42M in Q3 2014. 102 funds tracked by Wall St. Rank hold HRTX as of Q3 2015.

  • Forward Management reported no remaining Heron Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Forward Management sold 74,575 Heron Therapeutics shares in Q3 2015, an estimated $848K.
  • Forward Management first reported a position in Heron Therapeutics in Q1 2014 and held it in 4 quarters.
  • Forward Management's Heron Therapeutics position peaked at $1.42M in Q3 2014.
  • 102 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2015.

Based on Forward Management's 13F filing for Q3 2015, filed 9 Nov 2015.